An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study

Clinical trial NCT00402467 · COMPLETED

Trial details

NCT number: NCT00402467
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Venous Thromboembolism

Start date: 2004-02-01
Primary completion: 2004-11-01
Enrollment: 613

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.